These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 19883086)
1. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. Srinivasan B; Johnson TE; Lad R; Xing C J Med Chem; 2009 Nov; 52(22):7228-35. PubMed ID: 19883086 [TBL] [Abstract][Full Text] [Related]
2. Modulatory Effects of Chalcone Thio-Derivatives on NF-κB and STAT3 Signaling Pathways in Hepatocellular Carcinoma Cells: A Study on Selected Active Compounds. Papierska K; Judasz E; Tonińska W; Kubicki M; Krajka-Kuźniak V Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409068 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition. Zuo Y; Yu Y; Wang S; Shao W; Zhou B; Lin L; Luo Z; Huang R; Du J; Bu X Eur J Med Chem; 2012 Apr; 50():393-404. PubMed ID: 22386368 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds. Nian C; Gan X; Liu Q; Wu Y; Kong M; Zhang P; Jin M; Dong Z; Li W; Wang L; He W; Li X; Wu J Curr Med Chem; 2024; 31(39):6521-6541. PubMed ID: 38847254 [TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative effect of chalcone derivatives through inactivation of NF-κB in human cancer cells. Venkateswararao E; Sharma VK; Yun J; Kim Y; Jung SH Bioorg Med Chem; 2014 Jul; 22(13):3386-92. PubMed ID: 24835787 [TBL] [Abstract][Full Text] [Related]
6. A SAR study on a series of synthetic lipophilic chalcones as inhibitor of transcription factor NF-κB. Venkateswararao E; Sharma VK; Lee KC; Sharma N; Park SH; Kim Y; Jung SH Eur J Med Chem; 2012 Aug; 54():379-86. PubMed ID: 22677029 [TBL] [Abstract][Full Text] [Related]
7. Natural chalcones as dual inhibitors of HDACs and NF-κB. Orlikova B; Schnekenburger M; Zloh M; Golais F; Diederich M; Tasdemir D Oncol Rep; 2012 Sep; 28(3):797-805. PubMed ID: 22710558 [TBL] [Abstract][Full Text] [Related]
8. Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-κB signaling pathway. Gan FF; Zhang R; Ng HL; Karuppasamy M; Seah W; Yeap WH; Ong SM; Hadadi E; Wong SC; Chui WK; Chew EH Food Chem Toxicol; 2018 Jun; 116(Pt B):238-248. PubMed ID: 29630947 [TBL] [Abstract][Full Text] [Related]
9. Bis-chalcone analogues as potent NO production inhibitors and as cytotoxic agents. Vijaya Bhaskar Reddy M; Shen YC; Ohkoshi E; Bastow KF; Qian K; Lee KH; Wu TS Eur J Med Chem; 2012 Jan; 47(1):97-103. PubMed ID: 22115618 [TBL] [Abstract][Full Text] [Related]
10. Design and Discovery of Some Novel Chalcones as Antioxidant and Anti-Inflammatory Agents via Attenuating NF-κB. Chu J; Guo CL Arch Pharm (Weinheim); 2016 Jan; 349(1):63-70. PubMed ID: 26660296 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation. Monika ; Sharma A; Suthar SK; Aggarwal V; Lee HB; Sharma M Bioorg Med Chem Lett; 2014 Aug; 24(16):3814-8. PubMed ID: 25027934 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog. Warmka JK; Solberg EL; Zeliadt NA; Srinivasan B; Charlson AT; Xing C; Wattenberg EV Biochem Biophys Res Commun; 2012 Aug; 424(3):488-92. PubMed ID: 22771807 [TBL] [Abstract][Full Text] [Related]
13. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. Pandey MK; Sandur SK; Sung B; Sethi G; Kunnumakkara AB; Aggarwal BB J Biol Chem; 2007 Jun; 282(24):17340-50. PubMed ID: 17439942 [TBL] [Abstract][Full Text] [Related]
14. The aromatic ketone 4'-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition. Orlikova B; Tasdemir D; Golais F; Dicato M; Diederich M Biochem Pharmacol; 2011 Sep; 82(6):620-31. PubMed ID: 21703248 [TBL] [Abstract][Full Text] [Related]
15. Chalcone Derivatives: Role in Anticancer Therapy. Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802 [TBL] [Abstract][Full Text] [Related]
17. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice. Yang F; Li J; Zhu J; Wang D; Chen S; Bai X Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342 [TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Tse AK; Wan CK; Shen XL; Yang M; Fong WF Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of chalcone analogues incorporate α,β-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis. Zhu M; Wang J; Xie J; Chen L; Wei X; Jiang X; Bao M; Qiu Y; Chen Q; Li W; Jiang C; Zhou X; Jiang L; Qiu P; Wu J Eur J Med Chem; 2018 Sep; 157():1395-1405. PubMed ID: 30196062 [TBL] [Abstract][Full Text] [Related]
20. 2',4-Dihydroxy-3',4',6'-trimethoxychalcone from Chromolaena odorata possesses anti-inflammatory effects via inhibition of NF-κB and p38 MAPK in lipopolysaccharide-activated RAW 264.7 macrophages. Dhar R; Kimseng R; Chokchaisiri R; Hiransai P; Utaipan T; Suksamrarn A; Chunglok W Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):43-51. PubMed ID: 29199487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]